VIT 2.08% 9.4¢ vitura health limited

Ann: 2023 Financial Report, page-35

  1. 40 Posts.
    lightbulb Created with Sketch. 12
    The disparity of the 2023 H1 and H2 growth was explained in their results presentation as being the difference between inorganic and organic growth strategies and their focus in H2 of rolling out the platform. The management team advised that in 2024FY they are pushing the organic growth with the onboarding program and noted a couple of inorganic growth opportunities they are currently working on which are to be announced in due course.

    The huge SP spike in 2023 seemed to stem from both organic and inorganic growth announcements and then high volume.

    Overall, the Management team seemed very professional and aligned, this company is committed to and has demonstrated sustained year on year growth, the PE is currently below 15 and they seem to be well positioned in the market for scalable growth. I believe this is a great cheap stock at the moment which will inevitably go up once the downward pressure is released.

 
watchlist Created with Sketch. Add VIT (ASX) to my watchlist
(20min delay)
Last
9.4¢
Change
-0.002(2.08%)
Mkt cap ! $54.13M
Open High Low Value Volume
9.6¢ 9.6¢ 9.4¢ $5.642K 59.54K

Buyers (Bids)

No. Vol. Price($)
1 33058 9.5¢
 

Sellers (Offers)

Price($) Vol. No.
9.8¢ 19824 1
View Market Depth
Last trade - 15.59pm 21/06/2024 (20 minute delay) ?
VIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.